betulinic acid has been researched along with Prostatic Neoplasms in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, DS; Kim, JY; Koo, HM | 1 |
Arai, MA; Hosoya, T; Ishibashi, M; Kowithayakorn, T; Koyano, T; Tateno, C | 1 |
de Las Pozas, A; Palenzuela, D; Parrondo, R; Perez-Stable, C; Reiner, T | 1 |
Inn, KS; Jang, DS; Jo, SJ; Kim, HI; Kim, HJ; Kim, JE; Lee, CM; Lee, NR; Quan, FS | 1 |
Franco, D; Gupta, S; Shankar, E; Zhang, A | 1 |
de las Pozas, A; Parrondo, R; Perez-Stable, C; Rai, P; Reiner, T | 1 |
Ahn, KS; Choi, SH; Jeong, SJ; Jung, DB; Jung, JH; Kim, SH; Ko, SG; Lee, EO; Lee, HJ; Lee, SG; Shim, BS; Shin, J | 1 |
de Roo, GM; Kessler, JH; Medema, JP; Mullauer, FB | 1 |
Chintharlapalli, S; Papineni, S; Ramaiah, SK; Safe, S | 1 |
Das, B; Dasgupta, SB; Ganguly, A; Majumder, HK; Mukhopadhayay, S; Roy, A; Sen, N | 1 |
Gupta, S; Rabi, T; Shukla, S | 1 |
11 other study(ies) available for betulinic acid and Prostatic Neoplasms
Article | Year |
---|---|
Development of C-20 modified betulinic acid derivatives as antitumor agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Betulinic Acid; Drug Screening Assays, Antitumor; Humans; Male; Melanoma; Oleanolic Acid; Pentacyclic Triterpenes; Prostatic Neoplasms; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2001 |
Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana.
Topics: Animals; Betulinic Acid; Blotting, Western; Cell Survival; Cells, Cultured; Fibroblasts; Humans; Male; Maytansine; Mice; Oncogene Proteins; Pancreatic Neoplasms; Patched Receptors; Patched-1 Receptor; Pentacyclic Triterpenes; Phenols; Phenylethyl Alcohol; Plant Extracts; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transcription, Genetic; Triterpenes; Zinc Finger Protein GLI1; Zinc Fingers; Ziziphus | 2008 |
Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Male; Mice; Neovascularization, Pathologic; Pentacyclic Triterpenes; Peptide Hydrolases; Polyubiquitin; Prostatic Neoplasms; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteolysis; Triterpenes; Ubiquitination | 2013 |
Inhibition of estrogen signaling through depletion of estrogen receptor alpha by ursolic acid and betulinic acid from Prunella vulgaris var. lilacina.
Topics: Betulinic Acid; Breast Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Estrogen Receptor alpha; Estrogen Receptor Modulators; Estrogens; Female; Humans; Male; MCF-7 Cells; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plants, Medicinal; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Prunella; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Triterpenes; Ursolic Acid | 2014 |
Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Betulinic Acid; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Male; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Triterpenes; Tumor Suppressor Protein p53 | 2017 |
NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.
Topics: 2-Methoxyestradiol; Antineoplastic Agents; Apoptosis; Base Sequence; Betulinic Acid; Blotting, Western; Cell Line, Tumor; DNA Primers; Docetaxel; Estradiol; Flow Cytometry; Humans; Immunohistochemistry; Male; Mitosis; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Sesquiterpenes; Taxoids; Triterpenes | 2010 |
Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.
Topics: Angiogenesis Inhibitors; Betulinic Acid; Cell Death; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neovascularization, Pathologic; Pentacyclic Triterpenes; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; STAT3 Transcription Factor; Triterpenes; Vascular Endothelial Growth Factor A | 2011 |
Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Jurkat Cells; Lung Neoplasms; Male; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Triterpenes; Uterine Cervical Neoplasms | 2007 |
Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Growth Processes; Cell Line, Tumor; Humans; Inhibitor of Apoptosis Proteins; Liver; Male; Mice; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Proteins; Neovascularization, Pathologic; Pentacyclic Triterpenes; Promoter Regions, Genetic; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Sp Transcription Factors; Sp1 Transcription Factor; Sp3 Transcription Factor; Sp4 Transcription Factor; Survivin; Triterpenes; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2007 |
Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Death; Cell Line, Tumor; DNA, Neoplasm; Enzyme Inhibitors; Humans; Male; Pentacyclic Triterpenes; Prostatic Neoplasms; Reactive Oxygen Species; Topoisomerase I Inhibitors; Triterpenes | 2007 |
Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Genes, Reporter; Humans; Luciferases; Male; NF-kappa B; Pentacyclic Triterpenes; Prostatic Neoplasms; Tetrazolium Salts; Time Factors; Transfection; Triterpenes; Tumor Necrosis Factor-alpha | 2008 |